Uses of mannose-6-phosphate
AssigneeRenovo Limited
InventorsMark William James Ferguson, Sharon O'Kane, Nicholas Occleston, Kerry Nield, Tracey Mason, James Bush, Julian Hanak
Life of this patent
Estimating the term…
Abstract
There is provided the use of mannose-6-phosphate, or a salt, precursor or analogue thereof, for providing and/or maintaining a consistent skin colour, particularly to reducing redness of skin. There is also provided the use of mannose-6-phosphate, or a salt, precursor or analogue thereof, as a skin improvement agent for providing a cosmetic effect and mannose-6-phosphate, or a salt, precursor or analogue thereof, for use in treating normal or damaged skin, wherein damaged skin is skin that has been subject to epidermal and/or dermal damage.
Claims31
Mannose-6-phosphate, or a pharmaceutically or cosmetically acceptable salt, precursor, or analogue thereof, for use in reducing redness of skin.
Mannose-6-phosphate, or a pharmaceutically or cosmetically acceptable salt, precursor, or analogue thereof, for use in providing and/or maintaining a consistent skin colour.
Mannose-6-phosphate, or a pharmaceutically or cosmetically acceptable salt, precursor, or analogue thereof, for use as a skin improvement agent for providing a cosmetic effect.
Use of mannose-6-phosphate, or a salt, precursor, or analogue thereof, for reducing redness of skin.
Use of mannose-6-phosphate, or a salt, precursor, or analogue thereof, for providing and/or maintaining a consistent skin colour.
Use of mannose-6-phosphate, or a cosmetically acceptable salt, precursor, or analogue thereof, as a skin improvement agent for providing a cosmetic effect.
A cosmetic method for improving the skin of a subject, wherein the method comprises the step of administering an effective amount of mannose-6-phosphate, or a cosmetically acceptable salt, precursor, or analogue thereof, to the skin of the subject so as to provide a cosmetic effect to the skin.
A cosmetic composition comprising mannose-6-phosphate, or a cosmetically acceptable salt, precursor, or analogue thereof and a cosmetically acceptable carrier, wherein the carrier comprises around 1% to 50% by weight of the mannose-6-phosphate, or cosmetically acceptable salt, precursor, or analogue thereof.
A cosmetic composition comprising mannose-6-phosphate, or a cosmetically acceptable salt, precursor, or analogue thereof, and a cosmetically acceptable carrier, wherein the carrier comprises around 1% to 5% by weight of the mannose-6-phosphate, or cosmetically acceptable salt, precursor, or analogue thereof.
A cosmetic composition comprising mannose-6-phosphate, or a cosmetically acceptable salt, precursor, or analogue thereof, and a cosmetically acceptable carrier, wherein the carrier comprises around 1% to 3% by weight of the mannose-6-phosphate, or cosmetically acceptable salt, precursor, or analogue thereof.
A cosmetic composition comprising mannose-6-phosphate, or a cosmetically acceptable salt, precursor, or analogue thereof, and a cosmetically acceptable carrier, wherein the carrier comprises greater than 9% by weight, for example a range of greater than 9% to 50% by weight, of the mannose-6-phosphate, or cosmetically acceptable salt, precursor, or analogue thereof.
A chemical skin peel composition comprising mannose-6-phosphate, or a cosmetically acceptable salt, precursor, or analogue thereof, and an active chemical skin peel ingredient.
A chemical facial skin peel composition comprising mannose-6-phosphate, or a cosmetically acceptable salt, precursor, or analogue thereof, and an active chemical facial skin peel ingredient.
Mannose-6-phosphate, or a pharmaceutically acceptable salt, precursor, or analogue thereof, for use in treating skin that has been subject to damage, particularly damage to the epidermis and optionally the dermis.
Mannose-6-phosphate, or a pharmaceutically acceptable salt, precursor, or analogue thereof, for inhibiting the growth of bacteria on damaged skin.
Mannose-6-phosphate, or a pharmaceutically acceptable salt, precursor, or analogue thereof, for reducing swelling of damaged skin.
Dependencies are inferred from the claim text.